Matches in Wikidata for { <http://www.wikidata.org/entity/Q81321210> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q81321210 description "article scientifique publié en 2005" @default.
- Q81321210 description "artículu científicu espublizáu n'ochobre de 2005" @default.
- Q81321210 description "scientific article published on 01 October 2005" @default.
- Q81321210 description "wetenschappelijk artikel" @default.
- Q81321210 description "наукова стаття, опублікована в жовтні 2005" @default.
- Q81321210 name "Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?" @default.
- Q81321210 name "Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?" @default.
- Q81321210 type Item @default.
- Q81321210 label "Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?" @default.
- Q81321210 label "Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?" @default.
- Q81321210 prefLabel "Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?" @default.
- Q81321210 prefLabel "Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?" @default.
- Q81321210 P1433 Q81321210-2A713BA4-7CD0-4189-9CFD-1E0D4F24A2B7 @default.
- Q81321210 P1476 Q81321210-04543CBF-E7EE-4C9B-AD54-49CD468305BC @default.
- Q81321210 P2093 Q81321210-1DF73B0B-96B8-42F1-BA36-2C5AB9EE7119 @default.
- Q81321210 P2093 Q81321210-BB3BCD5B-53EF-42EB-9F5B-E9DFE444D34D @default.
- Q81321210 P304 Q81321210-9CF88557-89DD-4CEC-9BBC-C8B2FA02927E @default.
- Q81321210 P31 Q81321210-9067392F-2425-4C7F-A141-EF212B56CBE8 @default.
- Q81321210 P356 Q81321210-EDE4F116-EC48-4848-97B3-719E4719AE5F @default.
- Q81321210 P407 Q81321210-0E50E6CC-A299-46C5-9808-792F8DF9C3CF @default.
- Q81321210 P433 Q81321210-85EB3A2F-9DD0-49F6-B1C8-150B9F284041 @default.
- Q81321210 P478 Q81321210-811A7D0F-6D7F-47E0-BEDF-E4E4BE041CF9 @default.
- Q81321210 P577 Q81321210-59FAFEE5-6495-49D7-A263-4A24D7150992 @default.
- Q81321210 P698 Q81321210-E37FC4A2-4B50-47DD-8993-AE4A84C66377 @default.
- Q81321210 P921 Q81321210-64075CBF-3473-4E60-ACE2-705981E6577E @default.
- Q81321210 P356 J.AHJ.2005.08.001 @default.
- Q81321210 P698 16209959 @default.
- Q81321210 P1433 Q2227156 @default.
- Q81321210 P1476 "Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?" @default.
- Q81321210 P2093 "Abhinav Goyal" @default.
- Q81321210 P2093 "Michael Blazing" @default.
- Q81321210 P304 "650-651" @default.
- Q81321210 P31 Q13442814 @default.
- Q81321210 P356 "10.1016/J.AHJ.2005.08.001" @default.
- Q81321210 P407 Q1860 @default.
- Q81321210 P433 "4" @default.
- Q81321210 P478 "150" @default.
- Q81321210 P577 "2005-10-01T00:00:00Z" @default.
- Q81321210 P698 "16209959" @default.
- Q81321210 P921 Q844935 @default.